Press Releases

Rheonix Develops Fully Automated Microfluidic System that Improves HIV Testing

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, has completed development and testing of a microfluidic system and assay to simultaneously detect host anti-HIV antibodies and viral RNA in a single specimen of saliva or blood. The company’s findings are outlined in the recently published research article, “A Rapid, Self-confirming Assay for HIV: Simultaneous Detection of Anti-HIV Antibodies and Viral RNA” in the Journal of… Read More »

Rheonix to Present on Industrial Automation Solutions in the Lab at SLAS 2016

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will showcase its breakthrough molecular testing workstation, the Encompass Optimum™, in booth 537 at the Society for Laboratory Automation and Screening’s (SLAS) fifth annual conference and exhibition. The exhibition will be held at the San Diego Convention Center, Jan. 23-27. Rheonix will also participate in Festo Corp.’s workshop, “How Industrial Automation Solutions Improve Processes in the Lab… Read More »

Rheonix Inc. Raises $28.6 Million to Further Expand Commercialization Efforts of Molecular Diagnostic Technology

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, raised $28.6 million to further expand the company’s commercialization efforts for its breakthrough molecular testing platforms, the Encompass MDx® and Encompass Optimum™. The investment will also enable new product development and fund existing business needs. The funds are a combination of investments from existing international and domestic investors. Domestic investors include Advantage Capital Partners, Cayuga Venture Fund,… Read More »

Rheonix to Host Workshop and Showcase Easy-to-Use, Cost-Effective Molecular Diagnostic Technology at AMP 2015

ITHACA, N.Y. – Rheonix Inc., a developer of fully automated molecular testing solutions, will host a workshop at the Association for Molecular Pathology (AMP) 2015 Annual Meeting, which will be held Nov. 4-7 at the Austin Convention Center in Austin, Texas. The workshop, “Meeting the Challenges of the Changing LDT Landscape: Tools for Compliance,” will take place at 12 p.m., Nov. 4 in room 18B at the Convention Center. Throughout… Read More »

Rheonix Receives Patent for Device and Process That Will Improve Workflow and Lower Costs of Molecular Diagnostic Testing

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular diagnostics solutions, has been granted patent 9,132,398, “Integrated Microfluidic Device and Methods,” for the Rheonix CARD® cartridge, which enables assays to be performed on the company’s EncompassMDx® and Encompass Optimum™ instruments. The CARD, which stands for Chemistry and Reagent Device, will make molecular diagnostics simpler and easier to perform through an innovative and functional design that delivers a fully… Read More »

Rheonix to Showcase Breakthrough Technology That Addresses Obstacles in Molecular Testing at AACC Clinical Lab Expo

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will showcase its breakthrough molecular testing platform, the Encompass Optimum™ , at the American Association of Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Expo. The platform, for research use only, performs fully automated, complex molecular assays in an easy-to-use and economical format, addressing workflow and staffing obstacles laboratories face today. The AACC Clinical Lab Expo will… Read More »

Rheonix to Showcase Breakthrough Technology That Addresses Obstacles in Molecular Testing at asm2015

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will showcase its breakthrough molecular testing platform, the Encompass Optimum™ , at asm2015. The platform performs fully automated, complex molecular assays in an easy-to-use and economical format, addressing workflow and staffing obstacles that research laboratories are facing today. The 115th General Meeting of the American Society for Microbiology (ASM) will be held in New Orleans, May 30-June… Read More »

CBLS Genomics & Bioinformatics Core (GBC) Helps Evolve Molecular Diagnostics Industry: The Story of Rheonix

Rheonix®, Inc. has created a powerful microfluidic platform for the evolving molecular diagnostics industry that miniaturizes and automates all the functions of a molecular biology lab on a disposable chip the size of the palm of your hand. The Rheonix CARD® (Chemistry And Reagant Device) system incorporates disposable microfluidic chip technology and a scalable automated platform to analyze single or multiple clinical raw samples, providing multiplexed endpoint and/or real time analysis… Read More »

Rheonix Receives $1.5 Million Grant from the National Institute of Dental & Craniofacial Research to Complete Development of a Rapid Point-of-Care Test for HIV/AIDS

ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, has received a Small Business Innovation Research (SBIR) Phase II grant, under Award Number R44DE024456, from the National Institute of Dental & Craniofacial Research (NIDCR) of the National Institutes of Health (NIH). The grant will allow Rheonix to complete the development of a fully automated self-screening and confirming assay that can simultaneously detect HIV/AIDS antibodies and viral… Read More »

Rheonix to Present at Workshop on Industrial Automation Solutions in the Lab at SLAS 2015

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will participate in Festo Corp.’s workshop on “How Industrial Automation Solutions Improve Processes in the Lab” at the Society for Laboratory Automation and Screening’s (SLAS) fourth annual conference and exhibition. The press briefing for the workshop will be from 9:30 to 10:15 a.m., Feb. 10 at Booth 1123 at the Walter E. Washington Convention Center in Washington,… Read More »
Page 2 of 812345...Last »

Archives